PETNet to supply ACRIN trial

Siemens Healthcare PETNet Solutions has signed a deal to supply fluorine-18 sodium fluoride (F-18 NaF) and investigational fluorine-18 fluorothymidine (F-18 FLT) to the American College of Radiology Imaging Network (ACRIN) for use in clinical trials.

Availability of F-18 NaF and F-18 FLT will be made using a cross-reference system between Siemens drug master files and the National Cancer Institute's centralized investigational new drugs (INDs) system, through which the ACRIN trial will be performed.

F-18 FLT is used in PET studies to monitor proliferation of cancer cells and F-18 NaF will be studied for the detection of bony metastases. This cross-reference model permits both products to be produced and used by any principal investigator in an ACRIN clinical trial, according to Siemens of Malvern, PA.

Related Reading

PETNet signs supply deal with Lantheus, June 11, 2009

PETNet opens radiopharmacy in NC, March 25, 2009

PETNet, Covidien join forces, November 3, 2008

PETNet opens two radiopharmacies, June 16, 2008

Medrad, PETNet partner for FDG, June 13, 2008

Copyright © 2009

Page 1 of 436
Next Page